EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC

Fujing Ge, Hongdao Zhu, Xiangning Liu, Yuekang Li, Runqiu Guo, Chenming Zeng, Tao Yuan, Liu Yang, Xin Dong, Yulian Wu, Renhua Gai, Ronggui Hu und 4 weitere

Cell Reports · 2025-11 · 44 (11) · 116476

DOI: 10.1016/j.celrep.2025.116476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-11. Verfasst von Fujing Ge und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University…. Hauptthemen laut MEDLINE: Ubiquitin-Specific Peptidase 7, Deoxycytidine, Carcinoma, Pancreatic Ductal, RNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Specific Peptidase 7DeoxycytidineCarcinoma, Pancreatic DuctalRNA-Binding ProteinsPancreatic NeoplasmsCancer-Associated FibroblastsHumansGemcitabineCell Line, TumorAnimalsDrug Resistance, NeoplasmAutophagyMiceProtein StabilityPlatelet-Derived Growth FactorAdenosine

Stichwörter der Autor:innen

CP: CancerN(6)-methyladenosinePDGFRcancer-associated fibroblastsdeubiquitinasepancreatic ductal adenocarcinoma

Substanzen

Ubiquitin-Specific Peptidase 7DeoxycytidineRNA-Binding ProteinsGemcitabineIGF2BP2 protein, humanUSP7 protein, humanPlatelet-Derived Growth FactorN-methyladenosineAdenosine

Autor:innen und Institutionen

  • Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China.
  • Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.

Förderung

  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Ge, F., Zhu, H., Liu, X., Li, Y., Guo, R., Zeng, C., Yuan, T., Yang, L., Dong, X., Wu, Y., Gai, R., Hu, R., Zhou, T., He, Q., Zhu, H., & Yang, B. (2025). IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Cell Reports, 44(11), 116476. https://doi.org/10.1016/j.celrep.2025.116476

Vancouver

Ge F, Zhu H, Liu X, Li Y, Guo R, Zeng C, et al. IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Cell Reports. 2025;44(11):116476. doi:10.1016/j.celrep.2025.116476

BibTeX
@article{Ge2025,
  author = {Ge, Fujing and Zhu, Hongdao and Liu, Xiangning and Li, Yuekang and Guo, Runqiu and Zeng, Chenming and Yuan, Tao and Yang, Liu and Dong, Xin and Wu, Yulian and Gai, Renhua and Hu, Ronggui and Zhou, Tianhua and He, Qiaojun and Zhu, Hong and Yang, Bo},
  title = {IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {11},
  pages = {116476},
  doi = {10.1016/j.celrep.2025.116476}
}
Kostenlos starten →